Rigid Endoscopes Companies

The global rigid endoscopes market is projected to reach USD 2.32 billion by 2030, growing from USD 1.83 billion in 2025, at a CAGR of 4.9% during the forecast period.

The rigid endoscopes market is growing due to the rising demand for minimally invasive procedures, the increasing prevalence of chronic diseases such as neurological disorders and respiratory disorders, and technological advancements that enhance image quality and maneuverability. Moreover, the expanding geriatric population and improved reimbursement policies further drive adoption. However, market growth is restrained by high device costs, risk of cross-contamination despite reprocessing, and the availability of alternative diagnostic techniques.

Some of the key players in the rigid endoscopes market with a significant global presence include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), B. Braun SE (Germany), CONMED Corporation (US), Arthrex Inc. (US), Nipro (Japan), among others. These companies have adopted various organic and inorganic growth strategies, including acquisitions, product launches, approvals, and partnerships, to strengthen their international presence and increase their market share in the rigid endoscopes market. These strategies have enabled market players to expand their reach across different regions by offering rigid endoscopes.

To know about the assumptions considered for the study download the pdf brochure

In April 2025, KARL STORZ announced the launch of the Slimline C-MAC S single-use video laryngoscope, engineered for high-performance airway management. The device offers enhanced visualization for reliable intubation, even in complex clinical scenarios, while upholding the company’s renowned quality standards.

In January 2025, KARL STORZ SE & Co. KG (Germany) announced the strategic acquisition of its long-standing Swiss distributor, ANKLIN, to strengthen its direct sales presence in Switzerland. This move enhanced customer proximity and supported the delivery of tailored products and services in the MedTech sector.

In December 2022, Olympus Corporation acquired Odin Vision (UK), a cloud-AI endoscopy company with a strong portfolio of commercially available computer-aided detection/diagnostic (CAD) solutions and a deep innovation pipeline of cloud-enabled applications.

In November 2022, Richard Wolf and Arthrex collaborated to enhance healthcare and patient results in the U.S., providing a comprehensive range of surgical solutions for urology, gynecology, and general surgery, including advanced imaging, insufflation, instrumentation, and operating room integration.

Some of the prominent players operating in the market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), B Braun SE (Germany), CONMED Corporation (US), Arthrex Inc. (US), Nipro (Japan), and others.

Olympus Corporation (US)

Olympus Corporation is a key player in the rigid endoscopes market due to its comprehensive product portfolio, global presence, and strategic growth initiatives. The company operates through two main segments—Endoscopic Solutions and Therapeutic Solutions—covering a wide range of clinical specialties, including gastrointestinal, surgical, urology, respiratory, ENT, gynecology, and energy-based surgical procedures. Its Endoscopic Solutions segment provides gastrointestinal and surgical endoscopes along with related medical services, while the Therapeutic Solutions segment offers complementary devices that enhance procedural efficiency and patient outcomes. Olympus’s rigid endoscopes cater to critical procedures such as laparoscopy, hysteroscopy, and other minimally invasive surgeries, reinforcing its relevance across multiple high-demand applications. With 89 subsidiaries and 3 affiliates globally, Olympus ensures strong regional coverage, robust service capabilities, and rapid adoption of its technologies. The company’s commitment to precision engineering, durable design, and surgical efficiency strengthens its market positioning. Furthermore, Olympus actively pursues both organic growth and strategic acquisitions, exemplified by the January 2024 acquisition of Taewoong Medical Ltd., which enhances its GL Endo Therapy portfolio, broadens clinical capabilities, and improves patient care standards. These factors collectively solidify Olympus as a dominant and influential player in the rigid endoscopes market.

Karl Storz SE & CO. KG (Germany)

KARL STORZ SE & Co. KG is a leading player in the rigid endoscopes market, boasting a comprehensive portfolio of over 10,000 high-precision products for human and veterinary medicine. This underscores its commitment to innovation, diagnostic accuracy, and minimally invasive procedures. The company’s advanced rigid endoscopes span key clinical applications, including bronchoscopy, laryngoscopy, and neuroendoscopy, reinforcing its position in critical medical disciplines. Operating through 70 subsidiaries in more than 50 countries and maintaining production facilities in Germany, the US, Switzerland, Estonia, and China, the company ensures a robust global footprint that enables it to effectively address diverse regional healthcare needs. Its presence across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa supports strong customer engagement and reliable service delivery. Further cementing its leadership, KARL STORZ adopts strategic inorganic growth initiatives, including the acquisition of Surgical, Inc. (US) in August 2024, to expand its advanced surgical and endoscopic offerings. Through innovation, strategic partnerships, and operational reach, KARL STORZ remains a trusted and influential force in the global rigid endoscopes market.

Market Ranking

The ranking of firms in the rigid endoscopes market is based on market share analysis, secondary research, and validation from primary respondents. This rating considers revenue derived from the breadth and depth of the product portfolio, innovation, and approvals/launches. The rigid endoscopes market is consolidated, with five leading players—Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker (US), Smith+Nephew (UK), and B. Braun SE (Germany)—collectively accounting for more than 50% of the total market share. Olympus Corporation holds a prominent position due to its extensive and diversified portfolio of rigid endoscopes, which caters to multiple surgical specialties and strengthens its global footprint.

Karl Storz SE & Co. KG (Germany) has demonstrated a strategic approach to market expansion through both organic and inorganic growth initiatives, including the launch of its advanced Laryngoscope in April 2025 and the acquisition of Swiss distribution company ANKLIN in January 2025, enhancing its product offerings and distribution capabilities. Stryker (US), Smith+Nephew (UK), and B Braun SE (Germany) leverage their strong international presence to serve multiple therapeutic areas, including urology, gynecology, and laparoscopic procedures, ensuring wide market penetration and customer accessibility. These companies focus on technological innovations, product differentiation, and strategic partnerships to maintain competitiveness and address the evolving needs of healthcare providers. Collectively, the leading players in the rigid endoscopes market emphasize a combination of product portfolio expansion, global reach, and strategic initiatives to capture growing demand across surgical applications, ensuring sustained market leadership and reinforcing their position in an increasingly dynamic and technology-driven healthcare environment.

Related Reports:

Rigid Endoscopes Market by Type (Laparoscopes, Arthroscopes, Cystoscopes), Clinical Usage (Diagnostic, Surgical), Application (Laparoscopy, Cystoscopy, Arthroscopy, Other), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com